Nektar Technology is a music technology company that designs and manufactures innovative MIDI controllers, keyboard controllers, and software for music production and performance.

Nektar Technology, Inc.

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.

Pearl Therapeutics

Deerfield

SFJ Pharmaceuticals

AstraZeneca

New Enterprise Associates

Nektar Therapeutics

At #JPM2024 next week, Nektar’s management team will present on exciting company updates across our #immunology and #immunooncology pipelines. Learn more about us: https://bit.ly/47nZHVe

New preclinical data presented at #ASH23 by our collaborators at NYMC highlight that NKTR-255, in combination with obinutuzumab, expanded NK cells and enhanced antibody-dependent cellular cytotoxicity against rituximab-resistant Burkitt lymphoma cells. Learn more: https://bit.ly/48fE3DO

We’re celebrating Mary Tagliaferri, MD, Nektar’s Chief Medical Officer, who was recently named as one of Inc. Magazine’s 10 Most Eminent Women Leaders in Healthcare 2023. Learn more about Mary and the vital role she plays at Nektar directing clinical strategy, operations and medical affairs: https://bit.ly/3smei5l

At #EADVCongress this week, we presented new and encouraging responder data in late-breaking news oral presentation for Rezpegaldesleukin, our first-in-class selective T-reg therapy, in patients with #atopicdermatitis, also being studied in #alopeciaareata. Full press release: https://bit.ly/3M1sIye

We’re gearing up for #EADVCongress next week, where Nektar will have two presentations for Rezpegaldesleukin, our first-in-class selective regulatory T-cell therapy, being studied in #atopicdermatitis and #alopeciaareata. Additional details: https://bit.ly/3ZDSoXx

COM:NEKTARTECH

Nektar Therapeutics

Financials Not Available